title: Comparison of lopinavir level between the two formulations (soft-gel capsule and tablet) in HIV-infected pregnant women.
authors.forename: Marie-Aude
authors.initials: MA
authors.lastname: Khuong-Josses
authors.forename: David
authors.initials: D
authors.lastname: Azerad
authors.forename: Abdelghani
authors.initials: A
authors.lastname: Boussaïri
authors.forename: Dieudonné
authors.initials: D
authors.lastname: Ekoukou
mesh_terms: D000328:Adult; D002214:Capsules; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000097:blood*; D006801:Humans; D061466:Lopinavir; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000188:drug therapy*; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000627:therapeutic use*; D013607:Tablets
chemical_list: D002214:Capsules; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D013607:Tablets; D061466:Lopinavir